The use of rhBMP-2 for the treatment of congenital pseudarthrosis of the tibia: a case series.
Richards
B Stephens
BS
Texas Scottish Rite Hospital for Children, 2222 Welborn Street, Dallas, TX 75219, USA. steve.richards@tsrh.org
Oetgen
Matthew E
ME
Johnston
Charles E
CE
D000287:Administration, Topical; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005594:Fracture Fixation, Intramedullary; D006801:Humans; D007223:Infant; D036341:Intercellular Signaling Peptides and Proteins / Q000008:administration & dosage*; D008297:Male; D011542:Pseudarthrosis / Q000151:congenital / Q000188:drug therapy* / Q000601:surgery; D011994:Recombinant Proteins / Q000008:administration & dosage*; D012189:Retrospective Studies; D013977:Tibia / Q000002:abnormalities; D013978:Tibial Fractures / Q000150:complications*; D016212:Transforming Growth Factor beta / Q000008:administration & dosage*
D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D036341:Intercellular Signaling Peptides and Proteins; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; C499469:recombinant human bone morphogenetic protein-2